Torrent Pharmaceuticals Limited has informed the Exchange about General Updates
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals announced that the US FDA inspected its manufacturing facility at Vizag, Andhra Pradesh from July 28 to August 1, 2025. The inspection concluded with zero observations, meaning the regulator found no issues or deviations during the audit. This is the best possible outcome from a US FDA inspection, indicating full compliance with current Good Manufacturing Practices (cGMP) standards. The Vizag facility is one of Torrent's key manufacturing sites supplying products to the US market.
This is a positive development for Torrent Pharmaceuticals as it removes any near-term regulatory overhang on the Vizag plant, supporting uninterrupted supplies to the lucrative US market and reinforcing investor confidence in the company's manufacturing quality standards.